Loading company…
Won 6 federal SBIR/STTR research awards from HHS and other federal agencies.
REVEL PHARMACEUTICALS INC. has been awarded 6 US Small Business Innovation Research (SBIR/STTR) contracts totalling $2,942,757 between 2023 and 2025. These are non-dilutive federal research grants, not equity financing. The company is based in SAN FRANCISCO, California.
No investors recorded yet for REVEL PHARMACEUTICALS INC..
Add an investorREVEL PHARMACEUTICALS INC. has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for REVEL PHARMACEUTICALS INC..
Add diversity data